======= DDX54 ======= == Gene Information == * **Official Symbol**: DDX54 * **Official Name**: DEAD-box helicase 54 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79039|79039]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8TDD1|Q8TDD1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DDX54&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DDX54|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611665|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Has RNA-dependent ATPase activity. Represses the transcriptional activity of nuclear receptors. {ECO:0000269|PubMed:12466272}. |Helicase C| |DBP10CT| |DEAD| |intracellular estrogen receptor signaling pathway| |estrogen receptor binding| |RNA helicase activity| |intracellular steroid hormone receptor signaling pathway| |steroid hormone mediated signaling pathway| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |cellular response to steroid hormone stimulus| |rRNA processing| |rRNA metabolic process| |transcription corepressor activity| |ribosome biogenesis| |response to steroid hormone| |signaling receptor binding| |ncRNA processing| |ribonucleoprotein complex biogenesis| |ncRNA metabolic process| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |response to lipid| |nucleolus| |RNA processing| |response to hormone| |response to organic cyclic compound| |Golgi apparatus| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |RNA binding| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |ATP binding| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |RNA metabolic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.82| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-2.4| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-1.92| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-1.88| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.88| |[[:results:exp519|RS-1 10μM R08 exp519]]|-1.81| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.71| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.7| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|-1.7| |[[:results:exp359|FK-506 30μM R07 exp359]]|1.75| |[[:results:exp156|UNC2400 2μM R03 exp156]]|1.75| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.77| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|1.77| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|1.84| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|1.93| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|1.96| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.97| |[[:results:exp150|SGC0649 7μM R03 exp150]]|2.04| |[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|2.08| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|2.29| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.44| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.418| Global Fraction of Cell Lines Where Essential: 704/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|27/28| |bone|24/25| |breast|32/33| |central nervous system|55/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/15| |kidney|19/21| |liver|20/20| |lung|74/75| |lymphocyte|14/14| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|15/16| |plasma cell|15/15| |prostate|1/1| |skin|21/24| |soft tissue|7/7| |thyroid|2/2| |upper aerodigestive|21/22| |urinary tract|27/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 619 * **Expression level (log2 read counts)**: 7.27 {{:chemogenomics:nalm6 dist.png?nolink |}}